A 3D high content imaging-based screening assay for evaluating monotherapy and combination drug responses in patient tumors with endogenous immune cell populations intact.
Patient-relevant translational systems that better mimic the heterogeneity and molecular/genetic complexity of human tumors to:
Ex vivo testing protocols established for a wide range of solid tumors representing patient tumor biology
Tell us about your needs